01.

Historical Background: Generally by the word Bank we can easily understand that the financial institutions deal with money. Banking sector is expanding its hand in different events every day. At the same time the banking process is becoming faster, easier and the banking area becoming wider. As the demand for better services increases day by day, they are coming with different innovative ideas and management. In order to survive in the competitive field of the banking sector, all banking organization are looking for better service opportunities to provide their fellow clients. Since in recent years, internet has established its far reaching impact in every sector of our life, even it also has entered in the field of banking which is known as online banking. The main purpose of a bank is serving their clients and keeping their money safe. Besides this they also let their clients to earn a certain amount of interest on the money deposited with them. Traditional banks have been doing this, and internet banks continue the same function. The only difference is in the way the transactions are made. Today, many banks are internet only banks. Unlike their predecessors, these internet only banks do not maintain brick and mortar bank branches. Instead, they typically differentiate themselves by offering better interest rates and online banking features.

Like other countries online banking has also become popular in Bangladesh. Today many banks in Bangladesh provide their clients online banking facilities. Online banking allows us everything that we can in your regular banking institution besides it also provides more facilities than regular banking like the ability to transfer money from one account to another and to payees for bill payments, check history, reorders, and stop payments, check credit card balances and Statements, complete online loan applications, secure interactive messaging with staff, and much more.

02. Company Profile:

Incepta Pharmaceuticals Ltd. is now the 2nd largest company of the country and recognized as the fastest growing of the top five manufacturing company in the country. Established in the year 1999, the company has come a long way. This was the first time a local pharmaceutical company produced such highly sophisticated technology product in the country. Currently the Zirabo plant consists of several buildings with state of the art technology. Dedicated cephalosporin manufacturing building, a specialized manufacturing building for the production of lyophilized products, insulin and amino acids and newly built liquid and semisolid manufacturing building and large warehouse is also in operation. Incepta began its operation with a handful of highly skilled and dedicated professionals 1|Page

guided by an able leadership. Proper strategic planning, technical excellence, swift and timely decisions helped us achieve our objectives leading to much faster growth. Incepta was able to anticipate the need of the market and provide the right product at the right time. High focus on R&D investment from the very beginning made possible the introduction of quality products ahead of its competitors in most cases. Inceptas vision is to become a research based global pharmaceutical company in addition to being a highly efficient generic manufacturer. We would also like to discover and develop innovative, value-added products that improve the quality of life of people around the world and significantly contribute towards the growth of Bangladesh. It provides people globally with high quality health care products at affordable prices in order to improve access to medicine and to provide employees an enabling environment that facilitates realization of their full potential.

03. Product Profile:

The following product forms are manufactured on site: Sterile Products:

Liquid dosage forms (LVP & SVP, Terminally sterilized and aseptically filled ampoule) Eye Drops Solid dosage forms (Solid fill, Dry vials and Freeze-Dried Products)

Non Sterile Products:

Liquid dosage forms (Oral Liquid, Nasal Solution, Nasal Spray) Semisolid dosage forms (Creams, Ointments, Gels) Solid dosage forms (Tablets, Capsules, Powders, Granules)

Biological Products:

Aseptically prepared injectables: Erythropoetin, Enoxaparin, Insulin, Insulin Glargine (rDNA), Filgrastim

Cephalosporins (Dedicated manufacturing facilitiy):

Solid dosage forms (Tablets, Capsules, Powder) Sterile Powders (Aseptically filled vials)

2|Page

04. Competitive Position:

Since 1999, the Incepta name has been synonymous with the trust and reliability inherent in the word Quality. Quality is ingrained in the work of our colleagues and all our Values. We are dedicated to the delivery of quality healthcare throughout the nation. Our business practices and processes are designed to achieve quality results that exceed the expectations of patients, customers, colleagues, business partners and regulators. We have a relentless passion for Quality in everything we do. The QMS of Incepta Pharmaceuticals Limited is established in a frame to describe its operations in different documents and practices which is based on the principles of PICS and WHO guidelines. The Quality Manual describes the Quality Policy of Incepta Pharmaceuticals Limited. The Quality Assurance of Zirabo Plant consists of Quality Control, Quality Compliance and Quality Surveillance. The main tasks and duties of Quality Control have been described in the Quality Manual and relevant SOPs. The Head of Quality Assurance or his delegates are responsible for releasing drug substances, excipients, dosage forms and packaging materials. Quality Surveillance is responsible for the implementation of the Quality Management System in different areas in collaboration with different departments. Quality Surveillance play active role in conducting external and internal audits with their follow-ups. Incepta uses the robust technology which transfer mechanisms will be established and ensure products intented for commercial use continued to be manufactured, packaged and controlled using validated processes in qualified environments capable of meeting its high quality standard. Incepta now has one of the largest and competent sales force and large distribution network of its own, operated from 18 different locations throughout the country. A most dynamic skilled and dedicated marketing team comprising of pharmacists and doctors are at the core of the marketing operation. These highly skilled professionals play a crucial role in providing the necessary strategic guideline for the promotion of its product.

05. Business level Strategy pursues:

Around 4000 individuals from diverse disciplines including pharmacy, microbiology, MBA, Accounting, Engineering and Medicine are working nationwide under the umbrella of Incepta. All the skilled and professional personnel are set at their very appropriate responsible positions. Incepta has its own large distribution network having 18 depots all over the country. They make the products available in every single drug store of the country. The depots are located in Dhaka, Chittagong, Rajshahi, Khulna, Sylhet, Barisal, Comilla, Noakhali, Mymensingh, Magura, Bogra, Narayangonj, Rangpur, Dinajpur, Tangail, Jessor, Moulovibazar and Cox's Bazar. Incepta has already received approval from the European Union drug authorities. They have set a target to export medicines worth 10 million euro (Tk900 million) to EU nations in 2009. The company has set up an Active Pharmaceutical Ingredient (API) manufacturing facilities in the same year. At the home front, Incepta

3|Page

recorded a 17 per cent growth in 2008 when the country's medicine market grew 12 per cent, as it turnover crossed Tk 3.07 billion, just seven years after its inception. In 2009, the company pushed hard to achieve a domestic turnover of Tk4.50 billion and export of at least 20 million dollars.

International Marketing: During the course of the last couple of years the company has received accreditation from many other countries of the world and currently holds the following GMP certificates from their respective Ministry of Health.

European Union GMP Certificate Turkey GMP Certificate Yemen GMP Certificate Kenya GMP Certificate Democratic Republic of Congo GMP Certificate Ethiopia GMP Certificate Uganda GMP Certificate

Incepta currently sells its product in many countries of Asia, Africa, Central America and has started to sell in Latin America. Incepta is taking special efforts to ensure presence in the rest of the globe. Currently the company is exploring distributorship, contract manufacturing, in licensing, technology partnership and many other forms of cooperation. Companies around the world can benefit from partnership with Incepta as the company offers a very large portfolio of generic products to choose from. Focus on ensuring high quality and cost effectiveness makes our portfolio more attractive to potential customers. Quality Management System: The Quality Manual describes how testing instructions are established and used. The testing instructions include the specifications and testing methods. The testing instructions are binding for release testing and for follow-up stability testing. A routine inspection is being done in the name of "Self Inspection" mainly concerned with safety, sanitation and infra-structural facilities leading to GMP including documentation. Supply of raw materials are mainly obtained from approved suppliers. We select and evaluate the supplier as per procedures. This procedure is also applicable in case of supply of Primary and Secondary Packaging Materials. So the company is very much productive and profitable.

06. Trends of Performance:

4|Page

The mission, vision and objectives of Incepta Pharmaceuticals Ltd. is to provide people globally with high quality health care products at affordable prices in order to improve access to medicine and to provide employees an enabling environment that facilitates realization of their full potential. Day by day Incepta introduces new production strategies. Incepta Pharmaceuticals Limited has extended her range of services towards the highway of global market. Incepta pioneered the introduction of biotech products (Human Insulin) and lyophilized products (Pantoprazole injection) in the Bangladesh pharmaceutical market. To increase production Incepta Pharmaceuticals Limited creates new types of production units such as Maxsulin which is a new diabetic medication.

Incepta is guided by its export mission to improve the health and well-being of people worldwide. Its corporate philosophy is to create new value around health-related products through science and advanced technology. Incepta has always given very high priority to its Research and Development activities. This focus enabled Incepta to develop and market 118 generics for the first time ever in Bangladesh pharmaceutical market. The company has successfully developed nearly 650 dosage forms of 300 plus generics in different specialties that are currently selling in the local as well as international market. A total of 18 new generics with 37 presentations were launched this year. 11 of these generics were first ever in Bangladesh. Our Growth In Comparison With Local Pharma Market (IMS* Data) Up to June 2011 it has already launched more than 317 generics with a total of 624 presentations. The company produces a wide variety of dosage forms covering nearly all the major therapeutic classes. The company had a phenomenal growth of 448% over the previous year (IMS). On 15th January 2011, Incepta implemented globally acknowledged SAP software system. Incepta is the first Bangladeshi company to implement SAP to manage resources throughout the company operation. 5|Page

This world class resource management system will allow the company to become more efficient and effective in its day to day operation. Formulation & Development at Incepta R & D ensures:

Pre-formulation studies to check bio-chemical action of ingredients. Trials to assess efficiency and reproducibility of formulation (process validation) Stability study following ICH guide-line to check physical, chemical, and microbiological aspects of formulation. Standardize processes for uniform quality.

Transfer of technology to production department. Analytical method validation.

07. SWOT analysis:

Strengths Pioneer the introduction of biotech products (Human Insulin) and lyophilized products (Pantoprazole injection) in the Bangladesh. Offers top quality health care products at competitive price. Offers more than 100 new generics in Bangladesh for the 1st time. Offers facilities for contact manufacturing. Provide assistance in product promotion and training in overseas markets. High priority to its Research and Development activities. Strong distribution channel-supply right products in right places in right time. Using Robust technology and SAP software system. Weaknesses Some products such as vaccinations are not manufactured by Incepta Pharmaceuticals Limited. Opportunities Earning foreign remittances by exporting medicines which maintain international standards.

6|Page

 Possibility of earning more foreign currencies and saving more money by producing such type of products which are exported like vaccination and Insulin. Strengthen its position in the local and global market. Threats Others competitors such as Square Pharmaceuticals Limited are stronger than of Incepta Pharmaceuticals Limited. Some people though they are small in number still believe that foreign companies are better than native pharmaceuticals companies.

8. Possible Measures to Improve Performance:

By producing vaccinations which are imported from foreign countries because now-a-days people take more vaccination to get rid of various diseases. By making more product promotion through the medical promotion officers to make people aware that Incepta produces better products. By adopting more new technology such as Robust technology and SAP software system. The "Site Validation Master Plan" describes the strategy on qualification and validation covering Equipment Qualification, Process Validation, Cleaning Validation, Method Validation, System Validation, Personnel Validation etc. Training is a routine function. The training needs depend on the function of the employee. Departmental Manager and Supervisors define the training needs.A medical policy (health) exists for the employees.

Concluding remarks:
During the last 11 years of operation Incepta launched as many as 118 new generics for the first time ever in Bangladesh. High focus on quality and timely introduction of much needed essential medications previously unavailable in the country has enabled Incepta to become the second largest pharmaceutical company of the country.It has a strong quality management policy. To compete with other pharmaceuticals companies in the present market, Incepta strictly maintain Quality Management Systems. Incepta holds the no.2 position due to its the supreme quality and trendy attributes of its products. Its products are unique and have international standard. According to this report there is much dynamism in the performance of Square Pharmaceuticals Limited. In future Incepta will be the no.1 largest pharmaceutical company in Bangladesh.

7|Page

8|Page